Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 361 AL 375

Multifarious roles of mTOR signaling in cognitive aging and cerebrovascular dysfunction of Alzheimer's disease

Uddin MS, Rahman MA, Kabir MT, Behl T, Mathew B, Perveen A, Barreto GE, Bin-Jumah MN, Abdel-Daim MM, Ashraf GM.

IUBMB Life. 2020 Sep;72(9):1843-1855. doi: 10.1002/iub.2324. Epub 2020 May 30.

Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs

Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF.

Neuropharmacology. 2020 Oct 15;177:108099. doi: 10.1016/j.neuropharm.2020.108099. Epub 2020 Jun 7.

Placebo effect in subjects with cognitive impairment

Ito K, Romero K.

Int Rev Neurobiol. 2020;153:213-230. doi: 10.1016/bs.irn.2020.03.032. Epub 2020 Jun 9.

Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial

Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.

JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.

The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease

Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK.

Life Sci. 2020 Sep 15;257:118020. doi: 10.1016/j.lfs.2020.118020. Epub 2020 Jun 27.

Discontinued disease-modifying therapies for Alzheimer's disease: status and future perspectives

Imbimbo BP, Lozupone M, Watling M, Panza F.

Expert Opin Investig Drugs. 2020 Sep;29(9):919-933. doi: 10.1080/13543784.2020.1795127. Epub 2020 Jul 26.

The Effect of Hormone Replacement Therapy on Cognitive Function in Female Patients With Alzheimer's Disease: A Meta-Analysis

Zhou C, Wu Q, Wang Z, Wang Q, Liang Y, Liu S.

Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317520938585. doi: 10.1177/1533317520938585.

Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer's disease

Mihardja M, Roy J, Wong KY, Aquili L, Heng BC, Chan YS, Fung ML, Lim LW.

Ann N Y Acad Sci. 2020 Oct;1478(1):43-62. doi: 10.1111/nyas.14436. Epub 2020 Jul 22.

Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD)

Vidoni ED, Kamat A, Gahan WP, Ourso V, Woodard K, Kerwin DR, Binder EF, Burns JM, Cullum M, Hynan LS, Vongpatanasin W, Zhu DC, Zhang R, Keller JN.

J Alzheimers Dis. 2020;77(1):175-182. doi: 10.3233/JAD-200122.

Evaluation of the efficacy of pimavanserin in the treatment of agitation and aggression in patients with Alzheimer's disease psychosis: A post hoc analysis

Ballard CG, Coate B, Abler V, Stankovic S, Foff E.

Int J Geriatr Psychiatry. 2020 Nov;35(11):1402-1408. doi: 10.1002/gps.5381. Epub 2020 Aug 25.

Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy

Squitti R, Pal A, Picozza M, Avan A, Ventriglia M, Rongioletti MC, Hoogenraad T.

Biomolecules. 2020 Aug 9;10(8):1164. doi: 10.3390/biom10081164.

[Therapeutic perspectives in Alzheimer's disease]

Paquet C.

Rev Prat. 2020 Feb;70(2):170-172.

Repositioning medication for cardiovascular and cerebrovascular disease to delay the onset and prevent progression of Alzheimer's disease

Lee H, Kim E.

Arch Pharm Res. 2020 Sep;43(9):932-960. doi: 10.1007/s12272-020-01268-5. Epub 2020 Sep 9.

Drug repositioning and repurposing for Alzheimer disease

Ballard C, Aarsland D, Cummings J, O'Brien J, Mills R, Molinuevo JL, Fladby T, Williams G, Doherty P, Corbett A, Sultana J.

Nat Rev Neurol. 2020 Dec;16(12):661-673. doi: 10.1038/s41582-020-0397-4. Epub 2020 Sep 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias